Skip to main content

Exkurs: Progressive supranukleäre Blickparese

  • Chapter
  • 86 Accesses

Zusammenfassung

Steele, Richardson und Olszewksi beschrieben 1964 die nach ihnen benannte progressive supranukleäre Blickparese (progressive-supranuclear palsy — PSP) als eine klinisch-pathologisch abgrenzbare neurodegenerative Erkrankung (Steele et al. 1964). Vereinzelte klinische oder pathologische Berichte gehen jedoch z. T. um Jahrzehnte voraus (Goetz 1996). Die PSP ist neuropathologisch durch das Auftreten zahlreicher neurofibrillärer Bündel bzw. sog. „neuropil threads“ in bestimmten Regionen der Basalganglien und des Hirnstamms gekennzeichnet. Neuronaler Zellverlust und Gliose sind variabel ausgeprägt.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak R (1992) Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11-C-raclopride and positron emission tomography. Ann Neurol 31: 84–192

    Article  Google Scholar 

  • Brücke T, Wenger S, Asenbaum S, Fertl E, Pfafflmeyer N, Muller C, Podreka I, Angelberger P (1993) Dopamine D2 receptor imaging and measurement with SPECT. Adv Neurol 60: 494–500

    PubMed  Google Scholar 

  • Colosimo C, Albanese A, Hughes AJ, De Bruin V, Lees A (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease. Arch Neurol 55: 294–298

    Article  Google Scholar 

  • Goetz CG (1996) An early photographic case of probable progressive supranuclear palsy. Mov Disord 11: 617–618

    Article  PubMed  CAS  Google Scholar 

  • Jankovic J (1983) Controlled trial of pergolide mesylate in Parkinson’s disease and progressive supranuclear palsy. Neurology 33: 505–507

    Article  PubMed  CAS  Google Scholar 

  • Johnson RJ, Litvan I, Grafman J (1992) Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology 41: 1257–1262

    Article  Google Scholar 

  • Litvan I, Chase TN (1992) Traditional and experimental therapeutic approaches. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, New York, pp 254–269

    Google Scholar 

  • Litvan I, Mangone CA, Mckee A, Verny M, Parsa A, Jellinger K, D’Olhaberriague L, Chaudhuri RK, Pearce RKB (1996a) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 61: 615–620

    Article  Google Scholar 

  • Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D’Olhaberriague L, Verny M, Chaudhuri RK, Mckee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB (1996b) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46: 922–930

    Article  PubMed  CAS  Google Scholar 

  • Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996C) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Savoiardo M, Girotti F, Strada L, Cieri E (1994) Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm [Suppl] 42: 93–110

    Article  CAS  Google Scholar 

  • Schonfeld SM, Golbe LI, Sage JI, Safer JN, Duvoisin RC (1987) Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade. Mov Disord 2: 263–278

    Article  PubMed  CAS  Google Scholar 

  • Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–358

    Article  PubMed  CAS  Google Scholar 

  • Vidailhet M, Rivaud S, Gouider-Khouja N et al. (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35: 420–426

    Article  PubMed  CAS  Google Scholar 

  • Wenning GK, Pramstaller PP, Ransmayr G, Poewe W (1997) Atypische Parkinson-Syndrome. Nervenarzt 68: 102–115

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Wenning, G.K., Poewe, W. (1999). Exkurs: Progressive supranukleäre Blickparese. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6400-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6400-6_41

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7315-2

  • Online ISBN: 978-3-7091-6400-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics